Test Price
2,800 AED✅ Home Collection Available
CYP17A1 Genetic Sequencing (NGS) for 17α‑Hydroxylase Deficiency in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين CYP17A1 (تسلسل الجيل التالي) لِنَقْص 17‑ألفا‑هيدروكسيلاز في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Sequencing.
- Premium Logistics: Hospital‑Grade Home Collection (8 AM‑11 PM) with ISO Certified Cold‑Chain transport.
- Clinical Guidance: Complimentary telephonic post‑test interpretation with a DHA‑licensed clinical genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: فحص جيني بتقنية التسلسل من الجيل التالي (NGS) لجين CYP17A1 بدقة تشخيصية 99.9%، مع خدمة سحب منزلي طبي معتمدة، واستشارة ما بعد الفحص، ومتابعة تأمينية فورية عبر الواتساب.
Test Overview
This next‑generation sequencing (NGS) assay analyzes the entire coding region of the CYP17A1 gene to detect variants causing 17α‑hydroxylase/17,20‑lyase deficiency – a rare form of congenital adrenal hyperplasia. متوفر في جميع إمارات الدولة مع نتائج موثوقة خلال 3‑4 أسابيع.
| Feature | Our Test (InfoHealth UAE) | Closest Alternative |
|---|---|---|
| Precision | Full‑gene NGS with >99% analytical sensitivity | Targeted mutation panel (limited variants) |
| Method | Illumina® NextSeq, paired‑end 150bp | Sanger sequencing of selected exons |
| Speed | Report in 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocol
“Genetic results for 17α‑hydroxylase deficiency must be correlated with clinical, biochemical, and adrenal imaging findings. This test empowers informed family planning and precise glucocorticoid management, but it is never a substitute for a comprehensive endocrinology consultation.” – Dr. PRABHAKAR REDDY (DHA: 61713011)
⚠️ Important Medication Warning:
Do not discontinue prescribed corticosteroid or antihypertensive therapy without consulting your specialist. Abrupt withdrawal can precipitate life‑threatening adrenal crisis.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- Exclusion: Testing of minors without court‑approved parental consent or DHA‑mandated genetic counselling (as per UAE Child Genetic Screening Law 2026).
- Exclusion: Individuals currently experiencing or within 4 weeks of a red blood cell transfusion – may affect DNA purity.
- Exclusion: Inability to provide a valid Emirates ID or passport for identity verification.
- Emergency Red Flags (seek ER immediately): Severe hyponatremia, life‑threatening hyperkalemia, hypotension unresponsive to fluids, altered consciousness, or clinical signs of acute adrenal insufficiency.
✅ This service strictly complies with Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic data confidentiality, UAE PDPL (Federal Law No. 45 of 2021), and the 2026 Child Genetic Testing Regulation. Data is processed under ISO 9001:2015 certification (INT/EGQ/2509DA/3139) and DHA facility license 9834453.
Patient FAQ & Clinical Guidance
1. What does the CYP17A1 genetic test diagnose?
Snippet: This test identifies mutations in the CYP17A1 gene that cause 17α‑hydroxylase deficiency, a rare congenital adrenal hyperplasia disrupting cortisol and sex steroid synthesis.
The NGS assay sequences all exons and splice junctions, detecting point mutations, small indels, and copy number variations with clinical‑grade accuracy. Positive results guide lifelong hormone replacement therapy and genetic counselling for family members.
س1: ما الذي يكشفه اختبار الجين CYP17A1؟
يكشف هذا الفحص عن الطفرات في جين CYP17A1 المسببة لنقص إنزيم 17‑ألفا‑هيدروكسيلاز، وهو اضطراب نادر في تضخم الغدة الكظرية الخلقي.
2. How is the sample collected and when will I get the report?
Snippet: A single blood draw or DNA‑stabilized FTA card is collected at home by a DHA‑licensed phlebotomist, with results standardly delivered in 3 to 4 weeks.
Our cold‑chain VIP mobile service operates daily from 8 AM to 11 PM across all Emirates. An extracted DNA sample can also be accepted. The report is securely uploaded to your patient portal and reviewed during a tele‑counselling session.
س2: كيف تُسحب العينة ومتى تظهر النتيجة؟
يتم سحب عينة دم بسيطة أو بطاقة FTA منزلياً بواسطة ممرض معتمد، والنتيجة متاحة خلال 3‑4 أسابيع مع استشارة هاتفية.
3. Is this genetic covered by UAE health insurance?
Snippet: Many UAE insurers cover diagnostic CYP17A1 sequencing when pre‑authorized; our team verifies your policy via WhatsApp for direct billing options.
We coordinate with major networks including Daman, AXA, Oman Insurance, and Nextcare. A valid medical reason (e.g., ambiguous genitalia, unexplained hypertension/hypokalemia) increases approval. Send your insurance card to +971545488731 for immediate eligibility confirmation.
س3: هل يغطي التأمين الصحي في الإمارات هذا الاختبار الجيني؟
تغطي معظم شركات التأمين الفحص بعد الحصول على موافقة مسبقة؛ نتحقق من تغطيتك عبر الواتساب ونقدم خيار الفوترة المباشرة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians